Credit: Mashable Photo Composite / HP Deal pricing and availability subject to change ... device that’s made to travel and ...

HP has the best 360-degree convertible 2-in-1 you can buy, the brand-new Spectre x360 14. It’s a laptop offers genuinely useful media and tablet modes. HP also has an update to its largest 2-in ...

A slick design and a great OLED display can't offset the performance of HP's latest 14-inch Envy x360 convertible. Its low-wattage CPU is outpaced by the chips in some comparably priced rivals.

Other 16-inch laptops, notably the HP Pavilion Plus 16 and 2024 Dell XPS 16 can get 8 hours of battery life or more without ...

For a versatile but affordable device, check out the HP Pavilion 14 ... If you like speed and power but mostly work in Microsoft Office and browsers, the HP Spectre x360 14 2-in-1 laptop is ...

These are our favorite HP laptops from the company's OmniBook, Pavilion, Envy ... Because the iGPU splits space, memory and power with the CPU, it's better for smaller, lighter laptops, but ...

The Envy x360 2-in-1 is a more budget-class machine ... Both laptops have touch displays, and the HP supports an active pen. Connectivity is better on the Zenbook, with an additional Thunderbolt ...

There are many options for cable management, including Velcro straps that wrap around your cords to keep them bundled, bins that you drop your cords into that keep them out of sight, or clips that ...

The HP Chromebook Plus x360 14c offers good specs in exchange for its budget-friendly $800 price. Tech editor Kimberly Gedeon says this Chromebook “isn’t designed for power users, but it is ...

HP is currently offering up to $510 off a whole range of their laptops. Included in the sale are popular models such as Pavilion, Spectre as well as OMEN and Envy gaming laptops. They even offer ...

Cable companies have long contended with consumers who drop their TV bundles for streaming. But Comcast Corp. and Charter Communications Inc. are also losing subscribers on another front ...

Bourguignon, Lukas et al. systematically review the effect of drugs commonly administered after traumatic spinal cord injury on the neurological recovery in both animal studies and humans.